Myofascial Release in Patients With Chronic Obstructive Pulmonary Disease

Copd Clinical Trial

— MFR-COPD  

Official title:

Effects of Myofascial Release in Patients With Chronic Obstructive Pulmonary Disease: a Randomized Clinical Trial

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04260243
• Other study ID #: UNIVERSITY CARDENAL HERRERA-23
• Status: Not yet recruiting
• Phase: N/A
• Start date: March 2024
• Est. completion date: June 2025

Study information

• Verified date: November 2023
• Source: Cardenal Herrera University
• Contact: MARÍA DOLORES ARGUISUELAS, PhD
• Phone: 961369000
• Email: doloresarguisuelas[@]uchceu.es
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The main objective of this study is to assess the effects of a myofascial release protocol in patients with chronic obstructive pulmonary disease (COPD).

Description:

So far, there are no previous studies that analyze the effects of a myofascial relaxation protocol applied to the diaphragm within the respiratory rehabilitation treatment in patients with chronic obstructive pulmonary disease.

Aim: The main objective of this study is to assess the effects of a 3 weeks myofascial release protocol applied to the diaphragm on respiratory parameters in patients with chronic obstructive pulmonary disease.

Design: Randomized clinical trial

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 30
• Est. completion date: June 2025
• Est. primary completion date: March 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• COPD;

• Forced expiratory volume in the first second (FEV1) < 80%;

• FEV1/Forced vital capacity (FVC) < 70%;

• Maximal inspiratory pressure (MIP) < 70%.

Exclusion Criteria:

• Recent (6 months) spine or abdominal surgery;

• Allergic status of any kind;

• systemic diseases (rheumatic, infectious conditions, febrile state, vascular alterations, endocrine diseases including diabetes, metabolic, and neoplastic syndromes);

• neuromuscular or neurological injuries;

• previous myofascial release treatment.

Related Conditions & MeSH terms

• Copd
• Lung Diseases, Obstructive
• Pulmonary Disease, Chronic Obstructive

Intervention

Other:
• Experimental-Myofascial + Respiratory rehabilitation
6 sessions of: Myofascial Release (20 minutes each) + Respiratory rehabilitation (60 minutes each)
• Sham Myofascial + Respiratory rehabilitation
6 sessions of: Sham Myofascial Release (20 minutes each) + Respiratory rehabilitation (60 minutes each)

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Cardenal Herrera University

References & Publications (2)

Rocha T, Souza H, Brandao DC, Rattes C, Ribeiro L, Campos SL, Aliverti A, de Andrade AD. The Manual Diaphragm Release Technique improves diaphragmatic mobility, inspiratory capacity and exercise capacity in people with chronic obstructive pulmonary disease: a randomised trial. J Physiother. 2015 Oct;61(4):182-9. doi: 10.1016/j.jphys.2015.08.009. Epub 2015 Sep 19. — View Citation

Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, Lopez Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agusti A. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. Arch Bronconeumol. 2017 Mar;53(3):128-149. doi: 10.1016/j.arbres.2017.02.001. Epub 2017 Mar 6. Erratum In: Arch Bronconeumol. 2017 Jul;53(7):411-412. English, Spanish. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Quality of life measured with the Chronic Obstructive Pulmonary Disease Assessment Test: Score	Score (0-40) higher scores mean a worse outcome.	3 weeks
Secondary	6 Minutes Walking Test	Maximum distance reached	3 weeks